3 ML insulin aspart-xjhz 100 UNT/ML Pen Injector [Kirsty]
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
3 ML insulin aspart-xjhz 100 UNT/ML Pen Injector [Kirsty]
100 UNT/ML · Pen Injector · injection
A form of insulin aspart-xjhz →
3 ML insulin aspart-xjhz 100 UNT/ML Pen Injector [Kirsty] — Insulins and analogues for injection, fast-acting. Strength, form, class, interactions & more.
![3 ML insulin aspart-xjhz 100 UNT/ML Pen Injector [Kirsty]](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3db1d482-7e1f-aec6-79ef-3f305b4d8277&name=image-01.jpg)
Active ingredient
Classification
Insulins and analogues for injection, fast-actingInsulin Analog
Drug interactions
Insulin aspart may interact with various drugs that can either increase the risk of hypoglycemia or decrease its blood glucose lowering effect.
- majorantidiabetic agents — may increase the risk of hypoglycemia
- majorACE inhibitors — may increase the risk of hypoglycemia
- majorangiotensin II receptor blocking agents — may increase the risk of hypoglycemia
- majordisopyramide — may increase the risk of hypoglycemia
- majorfibrates — may increase the risk of hypoglycemia
- majorfluoxetine — may increase the risk of hypoglycemia
- majormonoamine oxidase inhibitors — may increase the risk of hypoglycemia
- majorpentoxifylline — may increase the risk of hypoglycemia
- majorpramlintide — may increase the risk of hypoglycemia
- majorsalicylates — may increase the risk of hypoglycemia
- majorsomatostatin analog (e.g., octreotide) — may increase the risk of hypoglycemia
- majorsulfonamide antibiotics — may increase the risk of hypoglycemia
- majoratypical antipsychotics (e.g., olanzapine and clozapine) — may decrease the blood glucose lowering effect
- majorcorticosteroids — may decrease the blood glucose lowering effect
- majordanazol — may decrease the blood glucose lowering effect
- majordiuretics — may decrease the blood glucose lowering effect
- majorestrogens — may decrease the blood glucose lowering effect
- majorglucagon — may decrease the blood glucose lowering effect
- majorisoniazid — may decrease the blood glucose lowering effect
- majorniacin — may decrease the blood glucose lowering effect
- majororal contraceptives — may decrease the blood glucose lowering effect
- majorphenothiazines — may decrease the blood glucose lowering effect
- majorprogestogens (e.g., in oral contraceptives) — may decrease the blood glucose lowering effect
- majorprotease inhibitors — may decrease the blood glucose lowering effect
- majorsomatropin — may decrease the blood glucose lowering effect
- majorsympathomimetic agents (e.g., albuterol, epinephrine, terbutaline) — may decrease the blood glucose lowering effect
- majorthyroid hormones — may decrease the blood glucose lowering effect
- majoralcohol — may increase or decrease the blood glucose lowering effect
- majorbeta-blockers — may increase or decrease the blood glucose lowering effect and may blunt signs and symptoms of hypoglycemia
- majorclonidine — may increase or decrease the blood glucose lowering effect and may blunt signs and symptoms of hypoglycemia
- majorlithium salts — may increase or decrease the blood glucose lowering effect
- majorpentamidine — may cause hypoglycemia, which may sometimes be followed by hyperglycemia
- unknownguanethidine — may blunt signs and symptoms of hypoglycemia
- unknownreserpine — may blunt signs and symptoms of hypoglycemia
Real-world adverse events (FAERS)
Product Packaging Confusion5Hypoglycaemia3Product Substitution Issue3Wrong Product Administered3Diabetes Mellitus Inadequate Control2Medication Error2Product Dose Omission Issue2Rash Pruritic2
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication